USD 0.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2009 | 75 Thousand USD | -51.9% |
2008 | 155.91 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2010 Q2 | 91.35 Thousand USD | 21.81% |
2010 Q3 | 92.71 Thousand USD | 1.49% |
2010 Q1 | 75 Thousand USD | 0.0% |
2009 Q2 | 75 Thousand USD | -52.91% |
2009 Q4 | 75 Thousand USD | 0.0% |
2009 Q3 | 75 Thousand USD | 0.0% |
2009 FY | 75 Thousand USD | -51.9% |
2009 Q1 | 159.28 Thousand USD | 2.16% |
2008 FY | 155.91 Thousand USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | 155.91 Thousand USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | -100.0% |
2006 Q3 | 3.45 Million USD | 135.87% |
2006 Q2 | 1.46 Million USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 85.0% |
Ansell Limited | 855.59 Million USD | 99.991% |
Ansell Limited | 857.2 Million USD | 99.991% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 99.665% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 20.93 Thousand USD | -258.252% |
Psykey, Inc. | 1.01 Million USD | 92.579% |
ConvaTec Group Plc | 1.31 Billion USD | 99.994% |
ConvaTec Group Plc | 1.31 Billion USD | 99.994% |
Encision Inc. | 1.33 Million USD | 94.374% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 96.751% |
Innovative MedTech Inc. | 1.87 Million USD | 96.007% |
LifePoint, Inc. | 446.74 Thousand USD | 83.212% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 98.61% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 96.574% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 242.64 Thousand USD | 69.091% |
SmileDirectClub, Inc. | 871.79 Million USD | 99.991% |
Sector 10, Inc. | 164 Thousand USD | 54.268% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.989% |
United Health Products, Inc. | 755.98 Thousand USD | 90.079% |
Vasamed, Inc. | 23.45 Thousand USD | -219.829% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 97.29% |
Yubo International Biotech Limited | 790.49 Thousand USD | 90.512% |